Investor Calendar
Upcoming Events
- No upcoming events -
Event Archive
Analyst Meeting for Q1/2023 result
Submission of Reviewed Financial Statement and MD&A for Q1/2023
Corporate Silent Period before Q1/2023 Results
The Company will neither discuss nor disclose any information related to Q1/2023 results
Annual General Meeting of Shareholders No. 1/2023 The meeting will be held electronically and broadcast live online only
The 2023 Annual General Meeting of Shareholders (E-AGM)
Analyst Meeting for YE 2022 results
Submission of Reviewed Financial Statement and MD&A for YE 2022
Corporate Silent Period before YE 2022 Results
The Company will neither discuss nor disclose any information related to YE 2022 results
Analyst Meeting for Q3/2022 results
Submission of Reviewed Financial Statement and MD&A for Q3/2022
Corporate Silent Period before Q3/2022 Results
The Company will neither discuss nor disclose any information related to Q3/2022 results
Opportunity Day Q2/2022
Analyst Meeting for Q2/2022 results
Submission of Reviewed Financial Statement and MD&A for Q2/2022
Corporate Silent Period before Q2/2022 Results
The Company will neither discuss nor disclose any information related to Q2/2022 results
Analyst Meeting for Q1/2022 result
Submission of Reviewed Financial Statement and MD&A for Q1/2022
Corporate Silent Period before Q1/2022 Results
The Company will neither discuss nor disclose any information related to Q1/2022 results
The 2022 Annual General Meeting of Shareholders (E-AGM)
Analyst Meeting for YE 2021 result
Submission of Reviewed Financial Statement and MD&A YE 2021
Corporate Silent Period before YE 2021 Results
The Company will neither discuss nor disclose any information related to YE 2021 results
Extraordinary General Meeting of Shareholders No. 1/2021 The meeting will be held electronically and broadcast live online only
Analyst Meeting for Q3/2021 result
Submission of Reviewed Financial Statement and MD&A for Q3/2021
Corporate Silent Period before Q3/2021 Results
The Company will neither discuss nor disclose any information related to Q3/2021 results